AAD.org Login
Create a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our
Create a non-member account if you are applying for membership or need to interact with AAD systems. Non-member accounts do not have access to the member-only sections of our
This cohort study investigates the long-term risk of autoimmune and autoinflammatory diseases among patients in South Korea who had a COVID-19 diagnosis using an extended…
A recent review highlighted the safety of topical clindamycin, a popular antibiotic treatment for acne vulgaris.
This retrospective case series compares vitiligo resulting from immune checkpoint inhibitor (ICI) therapy vs preexisting vitiligo among patients receiving ICI treatment for cancer.
Researchers investigated the potential causal relationship between primary biliary cirrhosis and psoriasis.
This case report describes a woman in her 40s who presented for evaluation of pruritic skin lesions on her chest and all 4 extremities that…
Deucravacitinib achieved ACR20 response in PsA patients at Week 16, with a safety profile consistent with previous studies.
As 2024 comes to a close, Dermatology Times is taking a look back at the studies, therapies, and advances in rosacea this year.
Dermatology Times is looking back on the top stories in dermatology from the month of December.
AAD Members, full access to the journal is a member benefit. Use your society credentials to access all journal content and features. As the newest…
We are pleased to invite you to the 2024 Psychiatry Update – a three-day meeting with renowned faculty and informative presentations on bipolar disorder, MDD,…